Character Biosciences
Biotechnology Research • 
San Francisco, California, United States • 21-50 Employees
Company overview
| Headquarters | San Francisco, California, United States |
| Website | |
| Founded | 2019 |
| Employees | 21-50 |
| Socials |
Key Contacts at Character Biosciences
Zachary Katz
Director, Strategic Initiatives & Alliance Management
Nick Olsen
Member Board Of Directors
Laura J. Szewczyk
Senior Director Clinical Operations
Kaila Smilen
Senior Director, Business Development & Corporate Strategy
Hsu-Hsin Chen
Director, Drug Discovery
Jonathan Gumucio
Director, Drug Discovery
Dinah Chen
Medical Director And Clinical Innovation Lead
Andrea Neeranjan
Associate Director
Wendy K. Lin
Associate Director Clinical Operations And Clinical Science
Dinah Chen
Medical Director
Character Biosciences Email Formats
Character Biosciences uses 4 email formats. The most common is {first name}.{last name} (e.g., john.doe@characterbio.com), used 48.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@characterbio.com | 48.7% |
{first initial}.{last name} | j.doe@characterbio.com | 41% |
{first initial} | j@characterbio.com | 5.1% |
{first name} | john@characterbio.com | 5.1% |
About Character Biosciences
Character Biosciences is a precision medicine company transforming drug development for progressive, polygenic diseases, beginning with ophthalmology. Our mission is to identify the genetic and molecular drivers of disease progression so we can develop targeted therapies for patients who urgently need them. We've built one of the most comprehensive resources in age-related eye diseases by partnering with over 150 ophthalmology clinics to integrate genetics with longitudinal clinical and imaging data. This deep phenotyping approach enables us to reclassify complex diseases like age-related macular degeneration (AMD) into genetically defined subtypes, unlocking novel therapeutic targets and optimizing patient selection for clinical trials. Character Bio’s AI-powered platform combines genomics, multi-modal data, and machine learning to discover and develop therapies that are more precise and more effective. Our lead programs, CTX114 and CTX203, are advancing toward clinical trials and are designed to slow or prevent vision loss in AMD patients. We are committed to delivering a new generation of precision medicines to treat and ultimately cure age-related blindness.
Character Biosciences revenue & valuation
| Annual revenue | $1,000,000 |
| Revenue per employee | $20,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $3,200,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Character Biosciences has 18 employees across 8 departments.
Departments
Number of employees
Funding Data
Character Biosciences has never raised funding before.
Character Biosciences Tech Stack
Discover the technologies and tools that power Character Biosciences's digital infrastructure, from frameworks to analytics platforms.
CDN
CDN
PaaS
JavaScript libraries
Miscellaneous
Security
Miscellaneous
Page builders
Font scripts
United Arab Emirates
New Zealand
Australia
United KingdomFrequently asked questions
4.8
40,000 users
